- Association of Plasma Ghrelin Levels with Insulin Resistance in Type 2 Diabetes Mellitus among Saudi Subjects
-
Ali Ahmed Al Qarni, Faris Elbahi Joatar, Nagalla Das, Mohamed Awad, Mona Eltayeb, Ahmed Gasim Al-Zubair, Muhalab E. Ali, Abdulaziz Al Masaud, Abdirashid M. Shire, Khalid Gumaa, Hayder A. Giha
-
Endocrinol Metab. 2017;32(2):230-240. Published online May 29, 2017
-
DOI: https://doi.org/10.3803/EnM.2017.32.2.230
-
-
5,876
View
-
58
Download
-
21
Web of Science
-
20
Crossref
-
Abstract
PDFPubReader
- Background
Although the exact mechanism of insulin resistance (IR) has not yet been established, IR is the hallmark characteristic of type 2 diabetes mellitus (T2DM). The aim of this study was to examine the relationship between plasma ghrelin levels and IR in Saudi subjects with T2DM. MethodsPatients with T2DM (n=107, cases) and non-diabetic apparently healthy subjects (n=101, controls) from Saudi Arabia were included in this study. The biochemical profiles and plasma insulin levels of all subjects were analyzed, and IR was estimated using the homeostatic model assessment of insulin resistance (HOMA-IR) index. Active ghrelin levels in plasma were measured using the radioimmunoassay technique. ResultsOnly 46.7% (50 of 107) of the T2DM subjects had IR, including 26% (28 of 107) with severe IR (HOMA-IR ≥5), while 5.9% (six of 101) of the controls had moderate IR (3 ≤HOMA-IR <5). HOMA-IR values were not associated with age, disease duration, or gender. Importantly, T2DM itself and the co-occurrence of IR with T2DM were significantly associated with low plasma ghrelin levels. However, ghrelin levels were inversely correlated with the HOMA-IR index, body weight, and fasting plasma insulin levels, mainly in the control subjects, which was indicative of the breakdown of metabolic homeostasis in T2DM. ConclusionThe prevalence of IR was relatively low, and IR may be inversely associated with plasma ghrelin levels among Saudi patients with T2DM.
-
Citations
Citations to this article as recorded by
- Leu72Met Polymorphism in Ghrelin Gene: A Potential Risk Factor for Hypertension in Type 2 Diabetes Patients
Monika Buraczynska, Jakub Golacki, Wojciech Zaluska Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 557. CrossRef - Hormonal and metabolic profiles of obese and nonobese type 2 diabetes patients: implications of plasma insulin, ghrelin, and vitamin D levels
Hayder A. Giha, Dhuha M. B. AlDehaini, Faris E. Joatar, Muhalab E. Ali, Einas M. Al-Harbi, Ali A. Al Qarni Cardiovascular Endocrinology & Metabolism.2022;[Epub] CrossRef -
Association of obesity in T2DM with differential polymorphism of ghrelin, growth hormone secretagogue receptor-1 and telomeres maintenance genes
Hayder A. Giha, Faris E. Joatar, Dhuha M. B. AlDehaini, Zainab H. A. Malalla, Muhalab E. Ali, Ali A. Al Qarni Hormone Molecular Biology and Clinical Investigation.2022; 43(3): 297. CrossRef - TLR4 mutation protects neurovascular function and cognitive decline in high-fat diet-fed mice
Nathalie Obadia, Giulia Andrade, Marina Leardini-Tristão, Letícia Albuquerque, Celina Garcia, Flavia Lima, Júlio Daleprane, Hugo C. Castro-Faria-Neto, Eduardo Tibiriçá, Vanessa Estato Journal of Neuroinflammation.2022;[Epub] CrossRef - Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study
Mohammad Muzaffar Mir, Rashid Mir, Mushabab Ayed Abdullah Alghamdi, Javed Iqbal Wani, Zia Ul Sabah, Mohammed Jeelani, Vijaya Marakala, Shahzada Khalid Sohail, Mohamed O’haj, Muffarah Hamid Alharthi, Mohannad Mohammad S. Alamri Journal of Personalized Medicine.2022; 12(5): 735. CrossRef - C-peptide is a predictor of telomere shortening: A five-year longitudinal study
Racha Ghoussaini, Hani Tamim, Martine Elbejjani, Maha Makki, Lara Nasreddine, Hussain Ismaeel, Mona P. Nasrallah, Nathalie K. Zgheib Frontiers in Endocrinology.2022;[Epub] CrossRef - Relationship Between Acyl and Desacyl Ghrelin Levels with Insulin Resistance and Body Fat Mass in Type 2 Diabetes Mellitus
Pu Zang, Cui-Hua Yang, Jun Liu, Hai-Yan Lei, Wei Wang, Qing-Yu Guo, Bin Lu, Jia-Qing Shao Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 2763. CrossRef - The Association of Pre-Transplant C-Peptide Level with the Development of Post-Transplant Diabetes: A Cohort Study
Amanda J. Vinson, Aran Thanamayooran, Bryce A. Kiberd, Kenneth West, Ferhan S. Siddiqi, Lakshman Gunaratnam, Karthik K. Tennankore Kidney360.2022; 3(10): 1738. CrossRef - Secondary analysis of gut hormone data from children with and without in utero exposure to gestational diabetes: Differences in the associations among ghrelin, GLP‐1, and insulin secretion
Ayse G. Zengul, Sarah ET Hoover, Paula C. Chandler‐Laney Pediatric Obesity.2021;[Epub] CrossRef - The Links of Ghrelin to Incretins, Insulin, Glucagon, and Leptin After Bariatric Surgery
Daria Skuratovskaia, Maria Vulf, Nataliya Chasovskikh, Aleksandra Komar, Elena Kirienkova, Egor Shunkin, Pavel Zatolokin, Larisa Litvinova Frontiers in Genetics.2021;[Epub] CrossRef - Анализ причин нарушения моторно-эвакуаторной функции желудка у больных с метаболическим синдромом
Сергей Николаевич Чернуха , Ирина Александровна Вильцанюк Естественные и Технические Науки.2021; (№05): 220. CrossRef - Variation analysis of Ghrelin gene in Chinese patients with obesity, having polycystic ovarian syndrome
Xiaomeng Wang, Fengxiang Qu, Chunlian Wang, Yan Wang, Dan Wang, Min Zhao, Xiangbing Yun, Qingmei Zheng, Lin Xu Gynecological Endocrinology.2020; 36(7): 594. CrossRef - Leu72Met polymorphism of GHRL gene decreases susceptibility to type 2 diabetes mellitus in a Mexican population
Edgar Alfonso Rivera-León, Mara Anaís Llamas-Covarrubias, Sergio Sánchez-Enríquez, Erika Martínez-López, Mercedes González-Hita, Iris Monserrat Llamas-Covarrubias BMC Endocrine Disorders.2020;[Epub] CrossRef - Ghrelin Levels and Decreased Kidney Function in Patients with Early Stages of Chronic Kidney Disease Against the Background of Obesity
Nataliia Vasylivna Gubina, Iryna Hryhorivna Kupnovytska, Vasyl Hryhorovych Mishchuk, Halyna Dmytrivna Markiv Journal of Medicine and Life.2020; 13(4): 530. CrossRef - Ghrelin fiber projections from the hypothalamic arcuate nucleus into the dorsal vagal complex and the regulation of glycolipid metabolism
Manqing Su, Meixing Yan, Yanling Gong Neuropeptides.2019; 78: 101972. CrossRef - Ghrelin deficiency in patients with type 2 diabetes: the relationships with obesity, adipose tissue dysfunction and glucose variability
V V Klimontov, D M Bulumbaeva, O N Fazullina, N B Orlov, V I Konenkov Terapevticheskii arkhiv.2019; 91(10): 28. CrossRef - The Correlation Between Circulating Ghrelin and Insulin Resistance in Obesity: A Meta-Analysis
Cai-Shun Zhang, Liu-Xin Wang, Rui Wang, Yuan Liu, Li-Min Song, Jun-Hua Yuan, Bin Wang, Jing Dong Frontiers in Physiology.2018;[Epub] CrossRef - Biomarker potential of C-peptide for screening of insulin resistance in diabetic and non-diabetic individuals
Haseeb A. Khan, Samia H. Sobki, Aishah Ekhzaimy, Isra Khan, Mona A. Almusawi Saudi Journal of Biological Sciences.2018; 25(8): 1729. CrossRef - Leu72Met and Other Intronic Polymorphisms in theGHRLandGHSRGenes Are Not Associated with Type 2 Diabetes Mellitus, Insulin Resistance, or Serum Ghrelin Levels in a Saudi Population
Faris Elbahi Joatar, Ali Ahmed Al Qarni, Muhalab E. Ali, Abdulaziz Al Masaud, Abdirashid M. Shire, Nagalla Das, Khalid Gumaa, Hayder A. Giha Endocrinology and Metabolism.2017; 32(3): 360. CrossRef - Expanded Normal Weight Obesity and Insulin Resistance in US Adults of the National Health and Nutrition Examination Survey
Keilah E. Martinez, Larry A. Tucker, Bruce W. Bailey, James D. LeCheminant Journal of Diabetes Research.2017; 2017: 1. CrossRef
|